Charles Schwab’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $904K | Buy |
233,506
+21,627
| +10% | +$83.7K | ﹤0.01% | 2930 |
|
|
2025
Q1 | $1.06M | Hold |
211,879
| – | – | ﹤0.01% | 2820 |
|
|
2024
Q4 | $1.53M | Buy |
211,879
+253
| +0.1% | +$1.82K | ﹤0.01% | 2759 |
|
|
2024
Q3 | $1.3M | Buy |
211,626
+4,772
| +2% | +$29.3K | ﹤0.01% | 2834 |
|
|
2024
Q2 | $1.38M | Buy |
206,854
+64,149
| +45% | +$427K | ﹤0.01% | 2820 |
|
|
2024
Q1 | $1.45M | Hold |
142,705
| – | – | ﹤0.01% | 2684 |
|
|
2023
Q4 | $1.61M | Buy |
142,705
+9,310
| +7% | +$105K | ﹤0.01% | 2681 |
|
|
2023
Q3 | $347K | Hold |
133,395
| – | – | ﹤0.01% | 3184 |
|
|
2023
Q2 | $471K | Buy |
133,395
+112,999
| +554% | +$399K | ﹤0.01% | 3082 |
|
|
2023
Q1 | $86.1K | Buy |
20,396
+3,122
| +18% | +$13.2K | ﹤0.01% | 3272 |
|
|
2022
Q4 | $284K | Hold |
17,274
| – | – | ﹤0.01% | 3124 |
|
|
2022
Q3 | $221K | Hold |
17,274
| – | – | ﹤0.01% | 3150 |
|
|
2022
Q2 | $203K | Sell |
17,274
-86,948
| -83% | -$1.02M | ﹤0.01% | 3240 |
|
|
2022
Q1 | $635K | Buy |
104,222
+3,402
| +3% | +$20.7K | ﹤0.01% | 3030 |
|
|
2021
Q4 | $924K | Buy |
100,820
+2,565
| +3% | +$23.5K | ﹤0.01% | 2944 |
|
|
2021
Q3 | $1.11M | Sell |
98,255
-114,295
| -54% | -$1.29M | ﹤0.01% | 2834 |
|
|
2021
Q2 | $2.09M | Buy |
212,550
+76,056
| +56% | +$749K | ﹤0.01% | 2701 |
|
|
2021
Q1 | $1.93M | Buy |
136,494
+14,973
| +12% | +$212K | ﹤0.01% | 2677 |
|
|
2020
Q4 | $1.37M | Buy |
121,521
+2,724
| +2% | +$30.7K | ﹤0.01% | 2688 |
|
|
2020
Q3 | $1.57M | Buy |
+118,797
| New | +$1.57M | ﹤0.01% | 2575 |
|
|
2017
Q2 | – | Sell |
-331
| Closed | -$81K | – | 3102 |
|
|
2017
Q1 | $81K | Hold |
331
| – | – | ﹤0.01% | 3026 |
|
|
2016
Q4 | $324K | Hold |
331
| – | – | ﹤0.01% | 2818 |
|
|
2016
Q3 | $289K | Hold |
331
| – | – | ﹤0.01% | 2804 |
|
|
2016
Q2 | $243K | Buy |
+331
| New | +$243K | ﹤0.01% | 2866 |
|